SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in patients with pre-existing neurodegenerative disorders: A systematic review with frequentist and Bayesian meta-analyses.

2023/05/30 by Molendijk, Marc, Kaburis, Melina, Smadi, Muhannad +3

paper · doi:10.17605/osf.io/fz5j4

Abstract

Are people with a previous medically-diagnosed (i.e., pre-existing) dementia or mild cognitive impairment (MCI) more likely to become infected with coronavirus disease 2019 (COVID-19)? And is the presence of a pre-existing dementia a risk factor for worse COVID-19 severity, or COVID-19 related hospital admission, ICU admission, or mortality?

Related

• Association between COVID-19 infection and new-onset dementia in older adults: a systematic review and meta-analysis
• Need for awareness and surveillance of long-term post-COVID neurodegenerative disorders. A position paper from the neuroCOVID‐19 task force of the European Academy of Neurology
• Long‐COVID‐19 Symptoms are associated with Abnormal Cognitive Testing and Mild Cognitive Impairment Compared to Controls
• Neurologic Manifestations of Long COVID Disproportionately Affect Young and Middle‐Age Adults
• ASSESSMENT AND CHARACTERIZATION OF COVID-19 RELATED COGNITIVE DECLINE: RESULTS FROM A NATURAL EXPERIMENT